To assess the relationship between members of the circulating microbiome and systemic inflammation, we measured the levels of lipopolysaccharide (LPS), interleukin (IL)-6, and IL-8 in both compartments of patients with cirrhosis and in the peripheral veins of the healthy controls. This evidence concerns the gene IL6 and Cirrhosis.